Stark COVID-19 Drug Shortages Warning From Senior EU Regulator
EMA Is Liaising With Firms On Potential Treatments And Vaccines
The deputy head of the European Medicines Agency has outlined the steps the agency is taking to assess and address the possibility of drug shortages in Europe caused by the coronavirus outbreak, as the number of cases worldwide tops the 98,000 mark.
You may also be interested in...
A public health advocacy group in the EU has issued tangible recommendations to address the perennial problem of drug shortages in the region.
The EU Partnership on Health Innovation, a new public private health care research partnership, is in the final drafting phase before its launch under Horizon Europe. In Vivo asked the partnership’s medtech industry lead, Patrick Boisseau, to set out the innovation challenges for participants as they address unmet health care needs in Europe.
The EU institutions are intensifying their efforts to mitigate the impact of COVID-19 on medicine provision, with a new group set to coordinate Europe-wide actions.